Philips North America vs SUN PHARMA /TARO: FDA Enforcement Comparison

Philips North America has been the subject of 369 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for SUN PHARMA /TARO.

Philips North America: 0 warning letters, 369 recalls, 0 approval records, 0 Form 483s.

SUN PHARMA /TARO: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.

Side by side

Philips North America — Warning letters0

SUN PHARMA /TARO — Warning letters0

Philips North America — Recalls369

SUN PHARMA /TARO — Recalls1

Philips North America — Approval records0

SUN PHARMA /TARO — Approval records0

Philips North America — Form 483s0

SUN PHARMA /TARO — Form 483s0

Timeline

Philips North America

Most recent FDA action: October 7, 2026

Full history →

SUN PHARMA /TARO

Most recent FDA action: September 23, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs SUN PHARMA /TARO: FDA Enforcement Comparison." Argus HQ, accessed October 13, 2026. https://argushq.ai/compare/philips-north-america-vs-sun-pharma-taro

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗